MetaCap

Enovis Financial Ratios

NYSE: ENOVHealth CareIndustrial SpecialtiesUSD

17.69+0.26 (+1.49%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Enovis ratio analysis

Enovis earned a net margin of -52.7% in FY 2025, down from -39.2% a year earlier. Gross margin was 59.8% compared with a median of 53.9% over the prior 9 years. Return on equity reached -79.5%, meaning Enovis generated -0.80 dollars of profit for every dollar of shareholders' equity.

Debt-to-equity stood at 0.87 versus 0.52 the year before, and the current ratio was 2.02. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.

Summary generated from market data by MetaCap's automated system. Methodology

Enovis financial ratios (annual)

Enovis annual financial ratios
RatioFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
P/E ratio (at fiscal year end)————56.5270.77—31.3855.9059.46
Price / sales0.671.131.791.852.842.682.592.004.342.39
Price / book1.020.930.890.840.880.852.511.342.402.62
Gross margin59.8%56.0%58.0%55.6%54.5%53.9%42.1%33.3%34.7%31.2%
Operating margin-50.0%-36.8%-3.8%-4.6%-4.4%-5.9%6.1%6.9%7.0%7.4%
Net margin-52.7%-39.2%-1.9%-0.9%5.0%3.8%-15.9%6.4%7.8%4.0%
Free cash flow margin0.9%-3.2%0.7%-10.3%17.7%16.7%0.2%7.1%7.7%5.8%
Return on equity (ROE)-79.5%-32.2%-1.0%-0.4%1.6%1.2%-15.3%4.3%4.3%4.4%
Return on assets (ROA)-30.9%-17.5%-0.7%-0.3%0.8%0.6%-7.1%2.1%2.3%2.0%
Debt / equity0.870.520.140.080.450.630.670.370.300.45
Current ratio2.022.172.431.412.251.681.641.631.891.64
Revenue growth6.7%23.5%9.2%9.6%27.3%-66.3%51.7%13.2%-39.2%-7.2%
EPS growth———-117.9%50.5%—-435.3%-4.9%17.3%-22.4%

Related